Biotech Startup Day 2015

When: September 16, 2015, 10:00 am - 7:30 pm
Where: Boston Marriott Copley Place, 110 Huntington Avenue Boston, MA 02116

Gain exposure to an audience of international dealmakers and early stage investors at the BioPharm America Startup Day. This program is specifically designed for early stage projects and young companies to get on the radar of the global life science community and to make the connections that matter.

10:00 – 10:45 AM Alternative partners roundtable

Clear methods are in place for how to approach pharma and even traditional investors but how do you get to the alternative partners that can make or break your startup? Venture philanthropists, patient groups, foundations and institutes discuss the best methods for getting the attention of all the other players.

Angus McQuilken – VP, Marketing and Communications, Massachusetts Life Sciences Center

* Christopher de Souza – Director, Broadview Ventures
* Gary M. Sclar – Associate Director, Dana-Farber Cancer Institute

11:00 – 11:45 AM Pharma Roundtable

Hear directly from your potential deal partners (large and small): What are they are looking for? Where do they source from? How do you get their attention? Execs from the leading pharma companies will share “dos and don’ts” and other helpful advice going into your afernoon pitches.


* Paola Casarosa – Corporate VP, Business Development and Licensing/Prescription Medicines, Boehringer Ingelheim GmbH
* Tomas Landh – Innovation Sourcing VP, Senior Principal Scientist, Novo Nordisk
* Melinda Richter – Head, Johnson and Johnson Innovation, JLABS

12:00 – 12:45 PM Investor Roundtable

Investors with backgrounds in traditional venture capital, angel investing, and venture philanthropy will highlight innovative financing methods for early stage companies. Building relationships and perfecting your pitch are keys to securing funding, so panelists will also discuss when and how to approach investors with your business proposition.

Steve Dickman – CEO, CBT Advisors

* Marian Nakada – VP, Venture Investments, Johnson and Johnson Innovation
* Isai Peimer – Managing Director, MedImmune Ventures
* Geeta Vemuri – Managing Partner, Baxalta Ventures

12:30 – 1:30 PM Lunch

1:30 – 7:30 PM Pitch sessions

Pitch your startup to a panel of judges comprising BD execs, venture capitalists, and industry experts!

Qualifying startup companies are invited to pitch their company using no more than four slides (or no slides if you dare!) in four minutes. Our top-notch panel of judges will determine the winner by the quality and effectiveness of the pitch.

Doug MacDougall – President, MacDougall Biomedical Communications

* Jeffrey Arnold – Member, Mass Med Angels and Boston Harbor Angels
* Thomas Luby – Senior Director, New Ventures, Johnson and Johnson Innovation, Boston
* Ivana Magovcevic-Liebisch – Senior VP and Head of Global Business Development, Teva Pharmaceuticals
* Jason Rhodes – Partner, Atlas Venture

Learn more »

Connect With Us

Blog Facebook LinkedIn Twitter